Current Challenges: Barriers to Care: AGA’s 12-Point Plan: Publication and Collaboration: Contact Information:
Browsing: Clinical Updates
Study Findings: Reasons for Unsatifactory FIT: Study Details: Proposed Solutions: Future Directions:
Survodutide Efficacy: Clinical Significance: Trial Details: Key Findings: Future Directions: Upcoming Presentations:
EoE Advancements: Managing EoE: Fecal Microbiota Therapies: Expert Insights on FMT: IBD and Fertility: Intestinal Ultrasound in Crohn’s:
The article discusses a study on the effectiveness of a proactive treat-to-target strategy in patients with Crohn’s disease (CD) who…
The article discusses the anticipated shortage of hepatologists in the United States by 2033 and the need for gastroenterologists to…
Dr. David Johnson discusses the American Cancer Society’s cancer statistics for 2024, highlighting some concerning trends, especially in gastrointestinal cancers.…
Two retrospective analyses have revealed that the introduction of biosimilars has reduced the costs of the originator biologic, infliximab, but…
A study using data from the National Health and Nutrition Examination Survey III revealed significant gender disparities in the risk…
Takeda Pharmaceutical Company announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first…